Insider at

04

Insider transactions

05
0 buys (P) 5 sells (S) Net: $-3,938,087 + 75 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

75 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Aug. 11, 2026 CVSA S 3,545 $130.34 $462,055 415,197 Direct -0.85% Disposed -3.7% (price as of 2026-10-02)
July 13, 2026 CVSA S 5,291 $132.75 $702,380 418,742 Direct -1.25% Disposed -5.5% (price as of 2026-10-02)
June 11, 2026 CVSA S 10b5-1 2,529 $130.78 $330,743 424,033 Direct -0.59% Disposed -4.1% (price as of 2026-10-02)
June 10, 2026 CVSA S 10b5-1 2,762 $130.14 $359,447 426,562 Direct -0.64% Disposed -3.6% (price as of 2026-10-02)
May 8, 2026 CVSA S 10b5-1 15,874 $131.25 $2,083,462 429,324 Direct -3.57% Disposed -4.4% (price as of 2026-10-02)
Nov. 9, 2021 CVSA P 1,000 $32.84 $32,840 144,027 Direct +0.70% Acquired 282.1% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Sept. 8, 2021 CVSA Non-qualified Stock Option (Right to Buy) Common Stock (68,745) $37.79 Sept. 8, 2031 68,745 Acquired
Sept. 8, 2021 CVSA Incentive Stock Option (Right to Buy) Common Stock (4,630) $37.79 Sept. 8, 2031 4,630 Acquired
Sept. 8, 2021 CVSA Incentive Stock Option (Right to Buy) Common Stock (4,630) $37.79 Sept. 8, 2031 4,630 Acquired
Sept. 8, 2021 CVSA Non-qualified Stock Option (Right to Buy) Common Stock (68,745) $37.79 Sept. 8, 2031 68,745 Acquired
Sept. 8, 2021 CVSA Incentive Stock Option (Right to Buy) Common Stock (4,630) $37.79 Sept. 8, 2031 4,630 Acquired
Sept. 8, 2021 CVSA Non-qualified Stock Option (Right to Buy) Common Stock (68,745) $37.79 Sept. 8, 2031 68,745 Acquired
Aug. 26, 2020 CVSA Employee Stock Option (Right to Buy) Common Stock (37,725) $32.03 Aug. 26, 2030 37,725 Acquired
Aug. 28, 2019 CVSA Employee Stock Option (Right to Buy) Common Stock (21,550) $43.39 Aug. 28, 2029 21,550 Acquired
Aug. 22, 2018 CVSA Non-qualified Stock Option (Right to Buy) [F2] Common Stock (7,323) $49.05 Aug. 22, 2028 7,323 Acquired
Aug. 22, 2018 CVSA Incentive Stock Option (Right to Buy) [F2] Common Stock (8,152) $49.05 Aug. 22, 2028 8,152 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Feb. 11, 2026 PLNT Class A Common Stock 0 Direct
Feb. 14, 2018 CVSA Common Stock · Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CVSA

CEO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 $828,466 · · · $258,388 · $97,779 $9,204,332
2021 $600,020 · · · $619,200 · $87,943 $2,801,880
2020 $597,558 · · · $562,723 · $40,534 $2,166,818

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.